This panel at Harvard Law School convened noted scientists, university administrators, IP lawyers and public health experts in a discussion of how university licensing practices can be changed to promote greater global access to university-researched medicine. This event was sponsored by Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics in collaboration with Ethics, Law and Biotechnology (ELaB), and the Harvard Law School chapter of Universities Allied for Essential Medicines (UAEM).

A webcast of the event is available here.